Background
==========

The mosquito-borne Japanese encephalitis virus (JEV) is an enveloped, positive-sense single-stranded RNA virus, member of the genus Flavivirus under the family Flaviviridae \[[@B1]\]. JEV is the sole etiologic agent of Japanese Encephalitis (JE); a neurotropic killer disease being one of the major causes of viral encephalitis in human. Since the isolation of this virus in Japan in 1935 \[[@B2]\], it has spread worldwide becoming a major public health problem. Worldwide case-fatality rate of JE was recorded to be 30% approximately with 30-50% of survivors developing permanent neurologic deficit/sequelae \[[@B3]\].

Recent studies have shown that the envelope (E) gene is an established phylogenetic marker for JEV, since this region is free from selective pressure that supports obscure long-term evolutionary relationship \[[@B4]\]. Altogether 5 distinct genotypes have been identified among the JEV strains \[[@B5]\] of which genotype III (GIII) is mostly circulated in the Southeast Asian countries, including Japan, South Korea, China, Taiwan, Vietnam, Philippines, and India \[[@B6]\]. However, it was recently documented that GIII is replaced by genotype I (GI) in South Korea, Thailand and China \[[@B7]\]. Though GIII is predominant in India, GI has been introduced in the country recently \[[@B7]\]. In 1973 JE outbreak was first recorded in the districts of Burdwan and Bankura in West Bengal where 700 cases and 300 deaths were reported \[[@B8],[@B9]\]. Thereafter, several JE outbreaks took place in the state \[[@B10]-[@B12]\]. Every year sporadic JE cases are being reported indicating its endemicity in this state despite the vaccination programme undertaken by the State Health Department, Government of West Bengal \[[@B13]\]. In addition, the geographic features, environmental factors and socio-economic status of this state also favor JEV transmission \[[@B14]\]. Moreover, the reports of JE incidences in the state are the indications of either partial coverage of the vaccine or the emergence of mutated/new strain of JEV. Genetic variation of JEV circulating in West Bengal has not yet been investigated and hence to ascertain the same a molecular epidemiological study was undertaken.

Materials and Methods
=====================

A total of 92 serum and 43 cerebrospinal fluid (CSF) samples were referred and/or collected from 135 clinically suspected pediatric-adolescent (0--20 years old) and adult (≥ 21 years old) individuals with Acute encephalitis syndrome (AES), showing high grade fever (≥39°c) for 2--15 days including any two of the following symptoms, viz. headache, vomiting, stupor, delirium, abnormal movements, presence of kernig's sign, convulsions, neck rigidity, altered sensorium, unconsciousness admitted in 8 different district hospitals, West Bengal during the period from July to December in 2010 (Figure [1](#F1){ref-type="fig"}).

![Map of West Bengal showing the location of sample collection areas.](1743-422X-9-271-1){#F1}

All the samples were tested for IgM antibody against JEV by using IgM antibody-capture (Mac) ELISA kit (National institute of virology, Pune, India), according to the manufacturer's protocol.

Only 61 JEV IgM negative samples with a history of ≤ 3 days' illness were screened and 200 μl of each of them were used for virus isolation on C6/36 cell line according to the standard protocol \[[@B13]\]. The tissue culture fluids were collected from the samples producing prominent cytopathic effect (CPE) and subjected for RNA extraction by QIAamp RNA viral kit (Qiagen, GmbH, Hilden, Germany), following the manufacturer's protocol.

To identify the isolates as JEV, reverse transcription-PCR (RT-PCR) was carried out with the extracted RNA (50 pg to 1μg) by Qiagen one step RT-PCR kit (Qiagen, GmbH, Hilden**,** Germany), in accordance with the manufacture's specifications, using 0.6 μM of primer pairs \[[@B13]\] that specific for structural E gene sequence of JEV. The PCR products were separated by electrophoresis on 1% agarose gel, stained with ethidium bromide.

RT-PCR amplicons were purified using the Qiagen gel extraction kit (Qiagen, GmbH, Hilden**,** Germany), according to the manufacturer's protocol, followed by direct sequencing using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA), as per the manufacturer's instructions and the products were analyzed using an automated DNA sequencer, 3130XL Genetic Analyzer (PE Applied Biosystems, Foster city, CA, USA). The 1,500 nucleotides generated complete sequences of the JEV E gene that were edited and corrected using the Finch TV software (<http://www.geospiza.com>). Multiple sequence alignment and phylogenetic analysis were performed by using CLUSTALW (<http://www.ebi.ac.uk/Tools/clustalw2/index.html>) and MEGA version 5.0 software (<http://www.megasofteware>. net). The phylogenetic tree was constructed by the neighbor-joining method, tested with Kimura 2-parameter model.

Results
=======

Out of 135 samples, only 36 (26.6%) samples were reactive to JEV specific IgM antibody, of which 23 (63.8%) and 13 (36.1%) samples were CSF and serum respectively. Only 61 of the remaining 99 JEV IgM negative samples having the history of ≤ 3 days of febrile illness were selected and subsequently subjected to tissue culture resulting in 19 samples producing prominent CPE of which only 13 (21.3%) samples were identified as JE positive by RT-PCR method, consisting of 8 (61.5%) from CSF and 5 (38.4%) from serum.

We have a total of 49 (36 IgM + 13 RT-PCR positive) JE cases (36.2%) of which 30 (19 IgM + 11 RT-PCR positive) were pediatric-adolescent (61.2%) and remaining 19 (17 IgM + 2 RT-PCR positive) were found to be adult cases (38.7%). Moreover, the occurrence of JEV infection was recorded during the month of July to December with the maximum number of cases (46.9%) observed in the month of September.

The Figure [2](#F2){ref-type="fig"} shows the phylogenetic tree derived from 13 E gene sequences of JEV isolates along with 41 previously published JEV strains, including 12 from India and 29 from worldwide (Table [1](#T1){ref-type="table"}). Dendrogram showed 2 E gene sequences of the isolates (GenBank: JN703381, JN703382) belonging to GI and comprising 89%-91% nucleotide (nt) identity with 11 E gene sequences of other isolates (GenBank: JN968468- JN968477, JN189785) belonging to GIII (Figure [2](#F2){ref-type="fig"}). Moreover, these 2 GI E gene sequences showed 99% nt similarity with each other and were most similar (96%) with Japanese GI strain Ishikawa (GenBank: AB051292), followed by 94%-95% nt similarity with Indian isolate JEV-GKP-0945054 (GenBank: HM156572). Eleven GIII E gene sequences showed 97%-99% nt similarity with each other and 93%-98% nt similarity with other Indian GIII strains, having the highest similarity (97%-98%) with Indian P20778 strain (GenBank: Z34096).

![**Phylogenetic analysis of 13 JEV isolates in serum/CSF samples from AES patients, West Bengal.** The Neighbor-Joining (NJ) Phylogenetic tree based on complete envelope (E) gene nucleotide sequences of Japanese encephalitis virus (JEV) isolates/strains. The Murray valley encephalitis virus strain (MVEV-1-51) was used as an out group for generating the rooted tree. The robustness of dendrogram was evaluated by 1000 bootstrap pseudo replicates. Bootstrap values (≥50% of replicates) were shown in corresponding nodes. Horizontal branch lengths are proportional to genetic distance and vertical branch lengths have no significance. Each taxon is named systematically by mentioning the accession number, strain name, country of origin and year of isolation. The isolates' sequences used in this study were marked with filled circle and triangle symbols. Genotypes are indicated on the right. Scale bar indicates nucleotide substitutions per site.](1743-422X-9-271-2){#F2}

###### 

Background information of selected strains/isolates of JEV referenced in this study

  **Strains/isolates**   **Country and Year of isolation**        **Source**    **Genotype**   **GenBank Accession no.**
  ---------------------- ---------------------------------------- ------------- -------------- ---------------------------
  Nakayama               Japan, 1935                              Human brain   III            U70413
  JaGAr01                Japan, 1959                              Mosquito      III            AF069076
  JaoArS982              Japan, 1982                              Mosquito      III            M18370
  Ishikawa               Japan, 1998                              Mosquito      I              AB051292
  JaNAr0102              Japan, 2002                              Mosquito      I              AY377577
  Fu                     Australia,1995                           Human         II             AF217620
  WTP-70-22              Malaysia ,1970                           Mosquito      II             U70421
  PhAn1242               Philipines,1984                          Pig serum     III            U70417
  Muar                   Malaysia, 1952                           Human         V              HM596272
  691004                 Srilanka, 1969                           Human         III            Z34097
  H49778                 Srilanka, 1987                           Human         III            U70395
  DH20                   Nepal, 1985                              Human         III            U03690
  VN118                  Vietnam, 1979                            Mosquito      III            U70420
  K94P05                 Korea, 1994                              Mosquito      I              AF045551
  KV1899                 Korea, 1999                              Pig           I              AY316157
  K91P55                 Korea, 1991                              Mosquito      I              U34928
  GP78                   India, 1978                              Human         III            AF075723
  733913                 India, 1973                              Human brain   III            Z34095
  P20778                 India, 1958                              Human         III            Z34096
  R53567                 India, unavailable                       unavailable   III            U70418
  782219                 India, 1982                              Human         III            U70402
  826309                 India, 1982                              Human brain   III            U70403
  R53567                 India, unavailable                       unavailable   III            U70418
  014178                 India, 2001                              Human blood   III            EF623987
  04940-4                India, 2002                              Mosquito      III            EF623989
  057434                 India, 2005                              Human blood   III            EF623988
  78124                  India, 1978                              Human         III            U70387
  JEV-GKP-0945054        India, 2009                              Human CSF     I              HM156572
  P3                     China, 1949                              Mosquito      III            U47032
  SA14                   China, 1958                              Mosquito      III            U14163
  SA14-14-2              China, unavailable                       Vaccine       III            D90195
  GZ04-36                China, 2004                              Mosquito      III            DQ404112
  XZ0934                 China, 2009                              Mosquito      V              JF915894
  SH-53                  China, 2001                              Mosquito      I              AY555757
  JKT1749                Indonesia, 1979                          Mosquito      II             U70405
  JKT9092                Indonesia, 1981                          Mosquito      IV             U70409
  JKT7003                Indonesia, 1981                          Mosquito      IV             U70408
  JKT5441                Indonesia, 1981                          Mosquito      II             U70406
  2372                   Thailand, 1979                           Human         I              U70401
  Chiang Mai             Thailand, 1964                           Human         III            U70393
  HK8256                 Taiwan, 1972                             Mosquito      III            U03691
  IND/10/WB              India, 2010                              Human CSF     III            JN189785
  IND/10/WB/JEV28        Midnapore, India, 2010                   Human CSF     I              JN703381
  IND/10/WB/JEV21        Midnapore, India, 2010                   Human CSF     I              JN703382
  IND/10/WB/JEV38        South 24 Pgs, West Bengal, India, 2010   Human CSF     III            JN968470
  IND/10/WB/JEV37        Hooghly, West Bengal, India, 2010        Human serum   III            JN968471
  IND/10/WB/JEV44        Malda, West Bengal, India, 2010          Human CSF     III            JN968468
  IND/10/WB/JEV41        Malda, West Bengal, India, 2010          Human CSF     III            JN968469
  IND/10/WB/JEV40        Howrah, West Bengal, India, 2010         Human CSF     III            JN968472
  IND/10/WB/JEV39        Birbhum, West Bengal, India, 2010        Human CSF     III            JN968473
  IND/10/WB/JEV42        Murshidabad, West Bengal, India, 2010    Human serum   III            JN968474
  IND/10/WB/JEV43        Murshidabad, West Bengal, India, 2010    Human serum   III            JN968475
  IND/10/WB/JEV35        Nadia, West Bengal, India, 2010          Human serum   III            JN968476
  IND/10/WB/JEV36        Nadia, West Bengal, India, 2010          Human serum   III            JN968477
  MVEV-1-51              Australia, 1951                          Human                        AF161266

All strains/isolates are JEV, except Murray valley encephalitis virus strain (MVE-1-51) used as out group for phylogenetic analysis in this study.

Discussion
==========

JEV infection is considered as a prime issue on public health concern in West Bengal. The present study reveals that 36/135 (26.6%) and 13/61 (21.3%) samples were positive to JE by Mac-ELISA and RT-PCR method respectively. This observation is the proof of JEV infection in recent time and to detect the total number of JE cases, ELISA negative acute samples (from ≤ 3 days' febrile illness) should be confirmed by RT-PCR test.

JE incidences (61.2% vs. 38.7%) were higher in pediatric-adolescent age group than adult because pediatrics were infected possibly due to lack of immunity and adolescents were directly exposed to the mosquito vector (*Culex* sp.) bite, as they usually took active part in cultivation in crop-fields where vectors usually breed. In the present study, JE was found to occur in the monsoon period with the maximum number of cases in September when the *Culex* mosquitoes breed in the paddy fields covered with stagnant rain water.

However, we found that 86 \[(99--61)+(61--13)\] samples with a history of 2--15 days' illness were true JE negative possibly due to either mishandling of samples which damaged the IgM antibody/the viral titre or the presence of another etiology responsible for AES.

In our previous reports we have achieved 36 JEV isolates \[[@B13]\] belonging to GIII whose E gene sequences were submitted to NCBI GenBank database like GenBank: JN189782, JN189783, JN189784 and HQ891146 etc. (unpublished data). The present study, therefore, constitutes the first report on E gene based phylogenetic analysis of the JEV isolates from AES cases of West Bengal where JEV GI has emerged very recently, co-circulating with JEV GIII.

Our study reveals that 2 isolates (GenBank: JN703381, JN703382) belonging to GI of JEV from the coastal district Midnapore (22.25°N 87.65°E and 23 meters above sea-level) where this GI might be transmitted from other part of India \[[@B7]\] or by the travellers returning from JE endemic countries, possibly with JEV infection \[[@B15]\]. On the other hand, this district has got many Lakes, swamps, forest and rice fields which provide a wintering and staging grounds for several migratory birds. Such areas are also very suitable for breeding and survival of mosquitoes. In view of these conditions, GI of JEV might have been introduced into West Bengal through migratory birds or cyclonic wind-blown mosquitoes from newer geographic region \[[@B16],[@B17]\]. However, it is still unknown as to how JEV GI has emerged in West Bengal exactly. Therefore, further studies to determine the role of travelers, migratory birds and wind-blown mosquitoes in JEV transmission are required.

The State Health Department of Government of West Bengal undertook the vaccination programme against JE in Midnapore in 2008 \[[@B13]\] using live attenuated JE vaccine derived from GIII strain SA-14-14-2. In this connection, the efficacy of the vaccine to protect against GI of JEV needs careful evaluation. In near future, there is a chance for an impending threat of JEV outbreak in this region/state, if this vaccine fails to protect sufficiently against GI of JEV.
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